logo
Melatonin: The wonder pill for sleep you still can't get hold of

Melatonin: The wonder pill for sleep you still can't get hold of

Telegraph26-07-2025
The desperation that comes with a bout of poor sleep is like nothing else. Brain fog, extreme fatigue and constant irritability are all traits of the regularly underslept. In the long term, so are obesity, high blood pressure and low mood – and we're increasingly aware of it. Scarcely more than a third of us say that the amount of sleep we get each night is 'good', a recent survey from Nuffield Health suggests.
Enter melatonin, the seemingly natural supplement with the promise to cure this very modern ailment. Melatonin is the hormone that our own brains produce to send us off to sleep each night. Your body naturally produces less melatonin as you age, with the process beginning around the age of 40 and escalates dramatically after 70.
In its synthetic form, filled into little white capsules or mixed into gummies, melatonin is available in supermarkets and on Amazon in the United States. It's also prescribed in Britain to people aged over 55 who have insomnia, and to children with ADHD or autism who struggle to sleep. Plenty more of us take melatonin occasionally for jet lag, even though you can't buy it over the counter in this country.
'When I see someone in clinic who is taking melatonin, the majority of the time, they've obtained it in this way rather than having been prescribed it,' says Dr Alanna Hare, a consultant in sleep and ventilation at Royal Brompton Hospital. There is a thriving middle-class black market for melatonin, which is legal to bring over from other countries or buy from online pharmacies, provided you don't sell it on.
Dr Hare has 'no doubt' that the desperate parents of children awaiting diagnoses for ADHD or autism find melatonin for them in this way too. Dr Cassie Coleman, a consultant paediatrician with a specialism in neurodiversity and child mental health, agrees. 'It's very common for parents to present at my clinic and tell me, with a huge amount of guilt, that they've accessed melatonin and are giving it to their children who either have ADHD or autism or are awaiting a diagnosis,' she says.
'Many parents are given some melatonin by their friends who also have neurodivergent children, after expressing just how exhausted they feel. Having a child who struggles to sleep can really upend family life, and it's often a massive source of anxiety and frustration for the child themselves too.'
When it comes to the effects of melatonin for families, 'the word 'life changing' is common,' says Dr Coleman. Melatonin supplements are considered 'very safe' to take, physically speaking, says sleep expert Dr Sophie Bostock. But while many people swear by it to help them drift off at night, research suggests that unless you have a specific sleep disorder, melatonin pills or chews are little more than placebo. So what's the truth about this highly sought-after sleep aid?
What is melatonin?
Melatonin is one of many hormones produced in your brain, with hormones being chemical messengers that signal different parts of your body to carry out different hormones. Specifically, melatonin is produced by the pineal gland, a tiny pinecone-shaped node (hence the name) that sits right in the middle of your brain. Other parts of the body like the eyes, skin and gut also produce some melatonin, but far less than is made by your pineal gland.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Fat jab users will go to dodgy online sellers if Mounjaro rollout is botched by NHS, drug bosses warn
Fat jab users will go to dodgy online sellers if Mounjaro rollout is botched by NHS, drug bosses warn

The Sun

time27 minutes ago

  • The Sun

Fat jab users will go to dodgy online sellers if Mounjaro rollout is botched by NHS, drug bosses warn

FAT jab users will go to dangerous sellers if the Mounjaro rollout is botched by the NHS, drugs bosses warn. Just eight of 42 health service boards offer the weight-loss injection after a launch in June, stats show. Under current plans it will take 12 years for all the 3.4 million eligible people to get it. Dr Emily Pegg of Lilly, which makes Mounjaro, told The Sun: 'We worry more people will be forced to seek it from potentially illegitimate and dangerous sources.' Dr Pegg warned social media sellers and dodgy online pharmacies posed a threat. She said: 'This is a prescription-only medication that comes with many rules and regulations. "A lot of people who are buying illicit medicines may not realise the potential danger.' Mounjaro is available on the NHS only to the most obese patients. More than 1.5 million Britons are thought to be taking weight-loss drugs, mostly on private prescription. Henry Gregg, from the National Pharmacy Association, said the NHS rollout was proceeding very slowly. He added: 'There are concerning reports of clinically ineligible patients trying to source medication from unregulated sources. 'This could pose a serious risk to a patients' health.' I've lost nearly 6 stone in 9 months on fat jabs - trolls call me 'lazy' & say it's the 'easy way out' but I don't care A Department of Health spokesman said: 'We expect NHS boards to be making these drugs available. "We are determined to bring revolutionary modern treatments to everyone who needs them.' 1

Novo Nordisk expands lawsuits against weight-loss drug compounders
Novo Nordisk expands lawsuits against weight-loss drug compounders

Reuters

timean hour ago

  • Reuters

Novo Nordisk expands lawsuits against weight-loss drug compounders

Aug 5 (Reuters) - Danish drugmaker Novo Nordisk ( opens new tab said on Tuesday it has filed 14 new lawsuits in the United States against the sale of unapproved versions of semaglutide, the main ingredient in its popular weight-loss and diabetes drugs, Wegovy and Ozempic. The new lawsuits target pharmacies and telehealth companies producing compounded versions of semaglutide "under the fake guise of personalization", Novo said, without naming the companies. Shares of major telehealth firm Hims & Hers (HIMS.N), opens new tab extended losses to fall nearly 13% in afternoon trade. It had earlier reported weaker-than-expected quarterly revenue. A Reuters search of legal filings found some cases filed by Novo in California dated Aug. 4 but none regarding San Francisco-based Hims. Hims was not immediately available for comment. Compounders copy brand-name medicines that are in short supply by combining, mixing or altering drug ingredients to meet demand. These companies were briefly allowed to produce hundreds of thousands of compounded doses of Novo's obesity and diabetes drugs when the Food and Drug Administration said they were in short supply. When the agency later banned the sale of these copies, Hims and Hers shifted to creating versions of semaglutide in personalized doses not accessible through the branded manufacturers. Novo's lawsuits allege that telehealth providers violate state corporate practice of medicine laws by improperly influencing doctors' decisions and steering patients toward knockoff compounded "semaglutide" under the guise of personalized medicine. In reality, these are knockoffs that have not been approved as safe and effective and are often made with illicit foreign active pharmaceutical ingredients (API), Novo said. It did not immediately respond to a Reuters query on which companies were being named in the lawsuit.

The genetic factor that could impact a child's future weight, according to experts
The genetic factor that could impact a child's future weight, according to experts

The Independent

time2 hours ago

  • The Independent

The genetic factor that could impact a child's future weight, according to experts

A mother's genes could play a role in determining a child's future weight – more so than a father's. Researchers at University College London (UCL) investigated how a parent's weight and genes influence their children's weight and diet from birth to age 17. To make the comparison, researchers used genetic and health data of 2,621 UK families in the Millennium Cohort Study, a UK birth cohort study of individuals born in 2001-2002. The study, published in the journal PLOS Genetics, looked at the BMI of parents and the birthweight of their children. They also looked at the child's diet at ages three, five, seven, 11, 14, and 17. Children's diets were assessed through self-reported records of how often and how much they consumed different food groups, including fruit, vegetables, fast food, and sugary drinks. Researchers then separated the direct effects of inherited genes from the indirect effects of genes that were not inherited. Study authors explained that non-inherited genes can still influence children's outcomes by influencing the development environment, such as conditions in the womb and parenting practices, as these are shaped by parents' genetics. Analysis revealed that while both parents' genetics influence a child's BMI, a mother's BMI continued to affect the child's weight beyond direct genetic inheritance. Researchers suggest this means genetic nurture, where a parent's genes shape the environment they create for their child, might be a big factor in a child's weight. This could be the case if a mother's genes influence her own weight, eating habits, or behaviours during pregnancy, which in turn can affect the child's development and long-term health. Dr Liam Wright, the study's lead author, said: ' Mothers ' genetics appear to play an important role in influencing their child's weight over and above the child's genetics. 'In addition to the genes mums directly pass on, our findings suggest that maternal genetics are instrumental in shaping the environment in which the child develops, therefore indirectly influencing the child's BMI too.' Almost a third of children aged two to 15 were considered to be obese or overweight in 2024, according to NHS data. However, researchers acknowledge BMI is not the most accurate way of measuring body fat, particularly among children, and so supplemented their analysis with several other adiposity-related measures, including fat mass. Dr Wright added: 'This isn't about blaming mothers, rather, supporting families to make a meaningful difference to children's long-term health. Targeted interventions to reduce maternal BMI, particularly during pregnancy, could reduce the intergenerational impacts of obesity."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store